The explosion of artificial intelligence has impacted every aspect of our lives. For synthetic biology, these algorithms are enabling us to synthesize and design solutions for some of our world's greatest challenges in ways that were previously impossible. This panel will explore the latest innovations of AI and synbio in antibody drug discovery and development, including the impact of these technologies to fundamentally disrupt the economics of drug discovery and development. Join us as leading experts in AI and drug development share their insights into the future of biotech and how burgeoning technologies in AI and synbio can work together to transform the paradigm of drug discovery to potentially accelerate the discovery of transformative new medicines for patients.